了解晚期早产患者和医生需要改进他们关于产前皮质类固醇的决策:一个定性框架分析。

CMAJ open Pub Date : 2023-05-01 DOI:10.9778/cmajo.20220139
Hannah Foggin, Rebecca Metcalfe, Jennifer A Hutcheon, Nick Bansback, Jason Burrows, Eda Karacebeyli, Sandesh Shivananda, Amelie Boutin, Jessica Liauw
{"title":"了解晚期早产患者和医生需要改进他们关于产前皮质类固醇的决策:一个定性框架分析。","authors":"Hannah Foggin,&nbsp;Rebecca Metcalfe,&nbsp;Jennifer A Hutcheon,&nbsp;Nick Bansback,&nbsp;Jason Burrows,&nbsp;Eda Karacebeyli,&nbsp;Sandesh Shivananda,&nbsp;Amelie Boutin,&nbsp;Jessica Liauw","doi":"10.9778/cmajo.20220139","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>It is unclear whether the benefits of administration of antenatal corticosteroids in late preterm gestation outweigh its harms. We sought to understand whether patients and physicians need increased support to decide whether to administer antenatal corticosteroids in late preterm gestation, and their informational needs and preferences for decision-making roles related to this intervention; we also wanted to know if creation of a decision-support tool would be useful.</p><p><strong>Methods: </strong>We conducted individual, semistructured interviews with pregnant people, obstetricians and pediatricians in Vancouver, Canada, in 2019. Using a qualitative framework analysis method, we coded, charted and interpreted interview transcripts into categories that formed an analytical framework.</p><p><strong>Results: </strong>We included 20 pregnant participants, 10 obstetricians and 10 pediatricians. We organized codes into the following categories: informational needs to decide whether to administer antenatal corticosteroids; preferences for decision-making roles regarding this treatment; the need for support to make this treatment decision; and the preferred format and content of a decision-support tool. Pregnant participants wanted to be involved in decision-making about antenatal corticosteroids in late preterm gestation. They wanted information on the medication, respiratory distress, hypoglycemia, parent-neonate bonding and long-term neurodevelopment. There was variation in physician counselling practices, and in how patients and physicians perceived the balance of treatment harms and benefits. Responses suggested a decision-support tool may be useful. Participants desired clear descriptions of risk magnitude and uncertainty.</p><p><strong>Interpretation: </strong>Pregnant people and physicians would likely benefit from increased support to consider the harms and benefits of antenatal corticosteroids in late preterm gestation. Creation of a decision-support tool may be useful.</p>","PeriodicalId":10432,"journal":{"name":"CMAJ open","volume":"11 3","pages":"E466-E474"},"PeriodicalIF":0.0000,"publicationDate":"2023-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/29/17/cmajo.20220139.PMC10212573.pdf","citationCount":"0","resultStr":"{\"title\":\"Understanding what patients and physicians need to improve their decision-making about antenatal corticosteroids in late preterm gestation: a qualitative framework analysis.\",\"authors\":\"Hannah Foggin,&nbsp;Rebecca Metcalfe,&nbsp;Jennifer A Hutcheon,&nbsp;Nick Bansback,&nbsp;Jason Burrows,&nbsp;Eda Karacebeyli,&nbsp;Sandesh Shivananda,&nbsp;Amelie Boutin,&nbsp;Jessica Liauw\",\"doi\":\"10.9778/cmajo.20220139\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>It is unclear whether the benefits of administration of antenatal corticosteroids in late preterm gestation outweigh its harms. We sought to understand whether patients and physicians need increased support to decide whether to administer antenatal corticosteroids in late preterm gestation, and their informational needs and preferences for decision-making roles related to this intervention; we also wanted to know if creation of a decision-support tool would be useful.</p><p><strong>Methods: </strong>We conducted individual, semistructured interviews with pregnant people, obstetricians and pediatricians in Vancouver, Canada, in 2019. Using a qualitative framework analysis method, we coded, charted and interpreted interview transcripts into categories that formed an analytical framework.</p><p><strong>Results: </strong>We included 20 pregnant participants, 10 obstetricians and 10 pediatricians. We organized codes into the following categories: informational needs to decide whether to administer antenatal corticosteroids; preferences for decision-making roles regarding this treatment; the need for support to make this treatment decision; and the preferred format and content of a decision-support tool. Pregnant participants wanted to be involved in decision-making about antenatal corticosteroids in late preterm gestation. They wanted information on the medication, respiratory distress, hypoglycemia, parent-neonate bonding and long-term neurodevelopment. There was variation in physician counselling practices, and in how patients and physicians perceived the balance of treatment harms and benefits. Responses suggested a decision-support tool may be useful. Participants desired clear descriptions of risk magnitude and uncertainty.</p><p><strong>Interpretation: </strong>Pregnant people and physicians would likely benefit from increased support to consider the harms and benefits of antenatal corticosteroids in late preterm gestation. Creation of a decision-support tool may be useful.</p>\",\"PeriodicalId\":10432,\"journal\":{\"name\":\"CMAJ open\",\"volume\":\"11 3\",\"pages\":\"E466-E474\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-05-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/29/17/cmajo.20220139.PMC10212573.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"CMAJ open\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.9778/cmajo.20220139\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"CMAJ open","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.9778/cmajo.20220139","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

背景:目前尚不清楚在晚期早产妊娠中使用皮质类固醇是否利大于弊。我们试图了解患者和医生是否需要更多的支持来决定是否在晚期早产中使用产前皮质类固醇,以及他们对这种干预相关决策角色的信息需求和偏好;我们还想知道创建决策支持工具是否有用。方法:我们于2019年对加拿大温哥华的孕妇、产科医生和儿科医生进行了个体、半结构化访谈。使用定性框架分析方法,我们将访谈记录编码、绘制图表并解释为类别,形成分析框架。结果:我们纳入了20名孕妇,10名产科医生和10名儿科医生。我们将代码分为以下几类:决定是否使用产前皮质类固醇的信息需求;对这种治疗的决策角色的偏好;做出这种治疗决定所需的支持;以及决策支持工具的首选格式和内容。怀孕的参与者希望在妊娠晚期参与有关产前皮质类固醇的决策。他们想了解有关药物、呼吸窘迫、低血糖、亲子关系和长期神经发育的信息。在医生咨询实践中,以及在患者和医生如何看待治疗危害和益处的平衡方面存在差异。答复表明,决策支持工具可能是有用的。参与者希望清楚地描述风险大小和不确定性。解释:孕妇和医生可能会受益于更多的支持,以考虑在晚期早产中使用产前皮质类固醇的危害和益处。创建一个决策支持工具可能是有用的。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Understanding what patients and physicians need to improve their decision-making about antenatal corticosteroids in late preterm gestation: a qualitative framework analysis.

Understanding what patients and physicians need to improve their decision-making about antenatal corticosteroids in late preterm gestation: a qualitative framework analysis.

Background: It is unclear whether the benefits of administration of antenatal corticosteroids in late preterm gestation outweigh its harms. We sought to understand whether patients and physicians need increased support to decide whether to administer antenatal corticosteroids in late preterm gestation, and their informational needs and preferences for decision-making roles related to this intervention; we also wanted to know if creation of a decision-support tool would be useful.

Methods: We conducted individual, semistructured interviews with pregnant people, obstetricians and pediatricians in Vancouver, Canada, in 2019. Using a qualitative framework analysis method, we coded, charted and interpreted interview transcripts into categories that formed an analytical framework.

Results: We included 20 pregnant participants, 10 obstetricians and 10 pediatricians. We organized codes into the following categories: informational needs to decide whether to administer antenatal corticosteroids; preferences for decision-making roles regarding this treatment; the need for support to make this treatment decision; and the preferred format and content of a decision-support tool. Pregnant participants wanted to be involved in decision-making about antenatal corticosteroids in late preterm gestation. They wanted information on the medication, respiratory distress, hypoglycemia, parent-neonate bonding and long-term neurodevelopment. There was variation in physician counselling practices, and in how patients and physicians perceived the balance of treatment harms and benefits. Responses suggested a decision-support tool may be useful. Participants desired clear descriptions of risk magnitude and uncertainty.

Interpretation: Pregnant people and physicians would likely benefit from increased support to consider the harms and benefits of antenatal corticosteroids in late preterm gestation. Creation of a decision-support tool may be useful.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信